Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 4681 AL 4695

Nursing and Parkinson's Disease: A Scoping Review of Worldwide Studies

Tosin MHS, Mecone CAC, Oliveira EFM, Tsui DS, Tan SB, Irene S, Oliveira BC, de Oliveira BGRB.

Clin Nurs Res. 2022 Feb;31(2):230-238. doi: 10.1177/10547738211044047. Epub 2021 Sep 6.

A Comparison of Functional Abilities in Individuals with Mild Cognitive Impairment and Parkinson's Disease with Mild Cognitive Impairment Using Multiple Assessment Methods

Schmitter-Edgecombe M, McAlister C, Greeley D.

J Int Neuropsychol Soc. 2022 Sep;28(8):798-809. doi: 10.1017/S1355617721001077. Epub 2021 Sep 6.

Probiotics: Potential novel therapeutics for microbiota-gut-brain axis dysfunction across gender and lifespan

Snigdha S, Ha K, Tsai P, Dinan TG, Bartos JD, Shahid M.

Pharmacol Ther. 2022 Mar;231:107978. doi: 10.1016/j.pharmthera.2021.107978. Epub 2021 Sep 4.

Perspective of preexcitation induced cardiomyopathy; early septal contraction, and subsequent rebound stretch

Miyazaki A, Uemura H.

J Cardiol. 2022 Jan;79(1):30-35. doi: 10.1016/j.jjcc.2021.08.017. Epub 2021 Sep 6.

Src family kinases (SFKs): critical regulators of microglial homeostatic functions and neurodegeneration in Parkinson's and Alzheimer's diseases

Portugal CC, Almeida TO, Socodato R, Relvas JB.

FEBS J. 2022 Dec;289(24):7760-7775. doi: 10.1111/febs.16197. Epub 2021 Oct 4.

Targeting α-synuclein aggregation and its role in mitochondrial dysfunction in Parkinson's disease

Haque ME, Akther M, Azam S, Kim IS, Lin Y, Lee YH, Choi DK.

Br J Pharmacol. 2022 Jan;179(1):23-45. doi: 10.1111/bph.15684. Epub 2021 Nov 24.

Systematic review and meta-analysis of randomised controlled trials on the effects of yoga in people with Parkinson's disease

Suárez-Iglesias D, Santos L, Sanchez-Lastra MA, Ayán C.

Disabil Rehabil. 2022 Oct;44(21):6210-6229. doi: 10.1080/09638288.2021.1966522. Epub 2021 Sep 17.

Unexpected ((123)I)FP-CIT SPECT findings: SWIDD, SWEDD and all DAT

Roberta B, Paolo B, Massimo F, Roberto E.

J Neurol. 2022 Feb;269(2):758-770. doi: 10.1007/s00415-021-10809-x. Epub 2021 Sep 18.

Effects of dry needling on gait and muscle tone in Parkinson's disease: a randomized clinical trial

Brandín-de la Cruz N, Calvo S, Rodríguez-Blanco C, Herrero P, Bravo-Esteban E.

Acupunct Med. 2022 Feb;40(1):3-12. doi: 10.1177/09645284211039232. Epub 2021 Sep 19.

Coding and Noncoding Variation in LRRK2 and Parkinson's Disease Risk

Lake J, Reed X, Langston RG, Nalls MA, Gan-Or Z, Cookson MR, Singleton AB, Blauwendraat C, Leonard HL; International Parkinson's Disease Genomics Consortium (IPDGC).

Mov Disord. 2022 Jan;37(1):95-105. doi: 10.1002/mds.28787. Epub 2021 Sep 20.

Narcolepsy genetic marker HLA DQB1*06:02 and excessive daytime sleepiness in Parkinson disease patients treated with dopaminergic agents

Adam O, Azher S, Valachovic E, Hahn A, Molho E.

J Neurol. 2022 May;269(5):2430-2439. doi: 10.1007/s00415-021-10813-1. Epub 2021 Sep 24.

Editorial for "Effects of Levodopa Therapy on Cerebral Arteries and Perfusion in Parkinson's Disease Patients"

Rovno HDS.

J Magn Reson Imaging. 2022 Mar;55(3):954-955. doi: 10.1002/jmri.27923. Epub 2021 Sep 24.

Brain regions susceptible to alpha-synuclein spreading

Guo YJ, Xiong H, Chen K, Zou JJ, Lei P.

Mol Psychiatry. 2022 Jan;27(1):758-770. doi: 10.1038/s41380-021-01296-7. Epub 2021 Sep 24.

Neurocritical care for neurological incapacitated patients

Ben Hadj Salem O.

Rev Neurol (Paris). 2022 Jan-Feb;178(1-2):105-110. doi: 10.1016/j.neurol.2021.08.003. Epub 2021 Sep 23.

Are Care-Recipient Outcomes Attributable to Improved Caregiver Well-Being? A Cluster-Randomized Controlled Trial of Benefit-Finding Intervention

Cheng ST, Chan WC, Lam LCW.

Am J Geriatr Psychiatry. 2022 Aug;30(8):903-913. doi: 10.1016/j.jagp.2021.08.009. Epub 2021 Aug 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias